X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs TORRENT PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD TORRENT PHARMA MERCK LTD/
TORRENT PHARMA
 
P/E (TTM) x 26.8 24.6 108.9% View Chart
P/BV x 3.0 6.0 49.8% View Chart
Dividend Yield % 0.9 3.3 28.5%  

Financials

 MERCK LTD   TORRENT PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
TORRENT PHARMA
Mar-16
MERCK LTD/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0601,720 61.6%   
Low Rs6231,134 55.0%   
Sales per share (Unadj.) Rs632.4394.5 160.3%  
Earnings per share (Unadj.) Rs45.7101.8 44.9%  
Cash flow per share (Unadj.) Rs62.3116.3 53.6%  
Dividends per share (Unadj.) Rs11.0040.00 27.5%  
Dividend yield (eoy) %1.32.8 46.6%  
Book value per share (Unadj.) Rs388.8200.3 194.2%  
Shares outstanding (eoy) m16.60169.22 9.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.6 36.8%   
Avg P/E ratio x18.414.0 131.3%  
P/CF ratio (eoy) x13.512.3 110.1%  
Price / Book Value ratio x2.27.1 30.4%  
Dividend payout %24.139.3 61.2%   
Avg Mkt Cap Rs m13,969241,435 5.8%   
No. of employees `0001.610.9 14.5%   
Total wages/salary Rs m1,4878,559 17.4%   
Avg. sales/employee Rs Th6,631.96,129.6 108.2%   
Avg. wages/employee Rs Th939.2785.8 119.5%   
Avg. net profit/employee Rs Th479.41,581.3 30.3%   
INCOME DATA
Net Sales Rs m10,49866,764 15.7%  
Other income Rs m2422,156 11.2%   
Total revenues Rs m10,74168,920 15.6%   
Gross profit Rs m1,13527,204 4.2%  
Depreciation Rs m2762,461 11.2%   
Interest Rs m01,859 0.0%   
Profit before tax Rs m1,10225,041 4.4%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-1,403 0.0%   
Tax Rs m3436,414 5.4%   
Profit after tax Rs m75917,224 4.4%  
Gross profit margin %10.840.7 26.5%  
Effective tax rate %31.125.6 121.6%   
Net profit margin %7.225.8 28.0%  
BALANCE SHEET DATA
Current assets Rs m6,41046,622 13.7%   
Current liabilities Rs m8,82832,843 26.9%   
Net working cap to sales %-23.020.6 -111.6%  
Current ratio x0.71.4 51.1%  
Inventory Days Days5874 77.7%  
Debtors Days Days3879 48.6%  
Net fixed assets Rs m1,40639,029 3.6%   
Share capital Rs m166846 19.6%   
"Free" reserves Rs m6,28631,400 20.0%   
Net worth Rs m6,45533,890 19.0%   
Long term debt Rs m018,637 0.0%   
Total assets Rs m8,82890,136 9.8%  
Interest coverage xNM14.5-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.7 160.5%   
Return on assets %8.621.2 40.6%  
Return on equity %11.850.8 23.1%  
Return on capital %17.148.5 35.2%  
Exports to sales %8.343.3 19.1%   
Imports to sales %21.06.9 306.5%   
Exports (fob) Rs m86928,934 3.0%   
Imports (cif) Rs m2,2094,584 48.2%   
Fx inflow Rs m95929,185 3.3%   
Fx outflow Rs m2,6126,021 43.4%   
Net fx Rs m-1,65323,165 -7.1%   
CASH FLOW
From Operations Rs m1,07027,132 3.9%  
From Investments Rs m-750-7,014 10.7%  
From Financial Activity Rs m-150-14,352 1.0%  
Net Cashflow Rs m1715,767 3.0%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 7.0 259.3%  
FIIs % 1.0 12.6 7.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 8.8 330.7%  
Shareholders   28,591 26,511 107.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   UNICHEM LAB  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SUN PHARMA  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 23, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS